Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Cytoreductive nephrectomy in metastatic papillary renal cell carcinoma

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 09.02.18
Views: 776

Dr Jeffrey Graham - Tom Baker Cancer Centre, Calgary, Canada

Dr Graham speaks with ecancer at the 2018 ASCO Genitourinary Cancers Symposium about a retrospective analysis of patients with papillary metastatic renal cell carcinoma treated with or without cytoreductive nephrectomy. 

He highlights that the use of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and papillary histology appears to be associated with improved survival when compared to no cytoreductive nephrectomy after adjustment for risk criteria.

Related videos

follow us

Siyemi immunocology e-learning

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation